Why you should bet on medical tech: Senior wealth strategist
Jill Garvey explains why Intuitive Surgical is a worthy investment on 'The Claman Countdown.'
Todos Medical CEO rips US government's COVID testing 'mess': 'This was very predictable'
Gerald Commissiong, president and CEO of Todos Medical, discusses how his company is developing testing solutions and new technology to address the 'lack of government support' on 'The Claman Countdown.'
Keiferx CEO on new method for treating Alzheimer's, neurodegenerative disease
Keiferx CEO Chris Hoyt on a 'cell garbage disposal mechanism' approach to treating Alzheimer's.
Cognition Therapeutics developing new treatment for Alzheimer's
Cognition Therapeutics CEO Lisa Ricciardi explains how advances in diagnostics and genetic markers is leading to developments in treating Alzheimer's.
Omicron will change the way people think: Infectious disease specialist
Dr. Amesh Adalja discusses the role of the COVID vaccine as new variants emerge on ‘Kennedy.’
Biotechnology related leases soaring due to high industry demand
Joel Marcus, executive chairman and founder of Alexandria Real Estate Equities, says the 2022 pipeline includes more than 8 million square feet in active development with more than 80% leased.
COVID testing is 'labor-intensive business': Prophase CEO
Prophase CEO Ted Karkus says the testing company has ramped up staffing efforts as COVID testing demand surges.
Gov. Hutchinson urges Biden to 'capitalize' on state flexibility, solutions for distributing at-home tests
Arkansas Gov. Asa Hutchinson argues Biden needs to get at-home COVID-19 testing kits 'produced' and sent to the states for distribution.
Rep. Steube slams CDC for flip-flopping on COVID recommendations
Rep. Greg Steube, R-Fla., argues 'you can't believe any of the information' that comes out of the Centers for Disease Control and Prevention.
Arkansas sets single day COVID case increase record
Gov. Asa Hutchinson, R-Ark., on rising omicron cases in his state, Biden claiming the solution to the virus is at the state level and Florida Gov. Ron DeSantis' handling of COVID testing.
CDC facing credibility crisis after mixed messaging creates confusion
Mt. Sinai Hospital Icahn School of Medicine Dr. Joel Zinburg discusses the CDC's mixed messaging on COVID guidelines and testing, the omicron variant and NYC considering race when distributing life-saving COVID treatments.
Chicago Teachers Union shutting down in-person classes is an 'absolute an overreaction': Dr. Contacessa
Northwell Health Internist Dr. Frank Contacessa discusses the Chicago Teachers Unions shutting down in-person learning over rising COVID cases, booster shots, omicron variant and the latest IHU variant emerging in France.
US needs 'quick ramp up' of COVID test production: eMed CEO
eMed co-founder and CEO Dr. Patrice Harris says the U.S. needs a better at-home testing protocol.
Elizabeth Holmes trial: Jury begins fifth day of deliberations in case against embattled Theranos founder
The California jury weighing the fate of embattled Theranos founder Elizabeth Holmes returns for its fifth day of deliberations on Tuesday in a trial that has captivated Silicon Valley.
At-home COVID test company ramps up production ‘on all fronts’: Intrivo Co-CEO
Intrivo co-CEO Ron Gutman says their at-home COVID tests are available online and at select retailers.
COVID testing developer releasing 10-minute result app
Intrivo co-CEO Ron Gutman discusses ‘2Gather,’ an at-home rapid test result meant to be taken ahead of gatherings.
The lockdown was one of the worst things for our nation: Dr. Nesheiwat
Fox News contributor Dr. Janette Nesheiwat says the vaccine remains the most effective in the fight against COVID.
Novavax vaccine will be 'very effective' against omicron: CEO
Novavax CEO Stanley Erck says the company will file with the U.S. Food and Drug Administration before the end of the year.
Co-Diagnostics developing at-home PCR test
Co-Diagnostics CEO Dwight Egan says his company is 'on the fast track' to make the tests available, noting that clinical trials should be complete in the first quarter and then will be submitted to the FDA for approval.
Novavax CEO says company at 'tipping point' with COVID vaccine
Novavax CEO Stanley Erck says the company is in the process of manufacturing 'quite a bit of doses and getting them out' and notes that the vaccine will be 'very effective' against the omicron strain.



















